National survey on prescription of cardiovascular drugs among outpatients with coronary artery disease in Switzerland.
Details
Download: 12644962.pdf (246.61 [Ko])
State: Public
Version: Final published version
State: Public
Version: Final published version
Serval ID
serval:BIB_F2427474079B
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
National survey on prescription of cardiovascular drugs among outpatients with coronary artery disease in Switzerland.
Journal
Swiss medical weekly
ISSN
1424-7860 (Print)
ISSN-L
0036-7672
Publication state
Published
Issued date
08/02/2003
Peer-reviewed
Oui
Volume
133
Number
5-6
Pages
88-92
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Abstract
Secondary prevention of coronary artery disease markedly reduces cardiovascular mortality and non-fatal endpoints. Outpatient care of subjects with coronary artery disease has been assessed in several European countries, but no current data is available for Switzerland.
A random sample of office-based physicians across Switzerland recorded current drug prescription of outpatients with coronary artery disease in the years 2000/2001 by means of a mail questionnaire. We assessed treatment frequencies according to different patient characteristics.
565 patients were included (mean age 68 +/- 11 years, 75% male). There was no evidence for differences in drug utilisation among the regions. Drug prescription rates for antithrombotic agents, beta-blockers, ACE-inhibitors/angiotensin receptor blockers and lipid lowering drugs were 91%, 58%, 50% and 63% respectively. Lower treatment rates were observed among patients >70 years and in those without a history of myocardial infarction or coronary revascularisation. Forty-nine percent of the patients had a blood pressure >140/>90, and 60% had lipid readings above the intervention cut-off according to the Swiss recommendations. Among those without a history of myocardial infarction or coronary revascularisation, the respective figures were 60% and 80%.
Compared to former surveys evidence based drug prescription has improved in Switzerland. Despite this, therapeutic goals for cholesterol levels and blood pressure are not being reached in a large proportion of patients. A high risk group for under use of evidence based drugs are patients without a history of myocardial infarction or coronary revascularisation.
A random sample of office-based physicians across Switzerland recorded current drug prescription of outpatients with coronary artery disease in the years 2000/2001 by means of a mail questionnaire. We assessed treatment frequencies according to different patient characteristics.
565 patients were included (mean age 68 +/- 11 years, 75% male). There was no evidence for differences in drug utilisation among the regions. Drug prescription rates for antithrombotic agents, beta-blockers, ACE-inhibitors/angiotensin receptor blockers and lipid lowering drugs were 91%, 58%, 50% and 63% respectively. Lower treatment rates were observed among patients >70 years and in those without a history of myocardial infarction or coronary revascularisation. Forty-nine percent of the patients had a blood pressure >140/>90, and 60% had lipid readings above the intervention cut-off according to the Swiss recommendations. Among those without a history of myocardial infarction or coronary revascularisation, the respective figures were 60% and 80%.
Compared to former surveys evidence based drug prescription has improved in Switzerland. Despite this, therapeutic goals for cholesterol levels and blood pressure are not being reached in a large proportion of patients. A high risk group for under use of evidence based drugs are patients without a history of myocardial infarction or coronary revascularisation.
Keywords
Adrenergic beta-Antagonists/therapeutic use, Aged, Ambulatory Care/statistics & numerical data, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Blood Pressure/drug effects, Cardiovascular Agents/therapeutic use, Cholesterol/blood, Coronary Artery Disease/blood, Coronary Artery Disease/drug therapy, Coronary Artery Disease/physiopathology, Drug Prescriptions/statistics & numerical data, Drug Utilization/statistics & numerical data, Female, Fibrinolytic Agents/therapeutic use, Health Care Surveys, Humans, Hypolipidemic Agents/therapeutic use, Male, Population Surveillance, Switzerland/epidemiology
Pubmed
Web of science
Create date
28/01/2008 11:45
Last modification date
20/08/2019 16:19